GeneBioTech Co. ,Ltd (KOSDAQ:086060)
South Korea flag South Korea · Delayed Price · Currency is KRW
4,780.00
-35.00 (-0.73%)
At close: Apr 28, 2026

GeneBioTech Co. ,Ltd Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2016
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2016
Cash & Equivalents
9,58710,2798,7517,4307,430
Upgrade
Short-Term Investments
15,31013,12513,2658,66010,360
Upgrade
Cash & Short-Term Investments
24,89723,40422,01616,09017,790
Upgrade
Cash Growth
6.38%6.31%36.83%-9.56%-35.04%
Upgrade
Accounts Receivable
12,38813,36411,58814,09010,225
Upgrade
Other Receivables
265.33356.36180.69183.8274.85
Upgrade
Receivables
12,98214,05311,81814,30210,371
Upgrade
Inventory
14,07417,04114,80215,45213,676
Upgrade
Prepaid Expenses
27.3927.2724.1625.6641.05
Upgrade
Other Current Assets
2,7301,310621.38399.76298.05
Upgrade
Total Current Assets
54,71155,83649,28146,26942,175
Upgrade
Property, Plant & Equipment
16,97213,92414,15914,61514,900
Upgrade
Long-Term Investments
2,406639.43718.86484.19763.6
Upgrade
Goodwill
---589.54589.54
Upgrade
Other Intangible Assets
582.66648.82632.02398.29199.07
Upgrade
Long-Term Deferred Tax Assets
71.1266.76205.29495.41870.49
Upgrade
Other Long-Term Assets
493.18436.81513666.71294.23
Upgrade
Total Assets
75,63471,98866,01764,04160,368
Upgrade
Accounts Payable
3,6543,3663,5403,9014,752
Upgrade
Accrued Expenses
1,1601,077970.5649.23515.74
Upgrade
Short-Term Debt
8,10910,8517,7049,4868,042
Upgrade
Current Portion of Long-Term Debt
1,9242,3591,5341,159-
Upgrade
Current Portion of Leases
76.1995.17132.9242.29112.39
Upgrade
Current Income Taxes Payable
413.78278.37284.2714.46-
Upgrade
Other Current Liabilities
377.37337.78347.33667.94716.5
Upgrade
Total Current Liabilities
15,71518,36414,51315,92014,139
Upgrade
Long-Term Debt
4,7822,4662,9952,3292,113
Upgrade
Long-Term Leases
66.38113.47135.0812.3533.57
Upgrade
Other Long-Term Liabilities
74.6872.0768.5453.02137
Upgrade
Total Liabilities
20,63821,01617,71218,31516,423
Upgrade
Common Stock
4,3054,3054,3054,3054,305
Upgrade
Additional Paid-In Capital
14,57614,57614,57614,57614,489
Upgrade
Retained Earnings
35,88931,80329,05918,11616,190
Upgrade
Comprehensive Income & Other
225.65288.42364.078,7298,961
Upgrade
Total Common Equity
54,99650,97248,30545,72643,945
Upgrade
Shareholders' Equity
54,99650,97248,30545,72643,945
Upgrade
Total Liabilities & Equity
75,63471,98866,01764,04160,368
Upgrade
Total Debt
14,95715,88512,50213,02910,302
Upgrade
Net Cash (Debt)
9,9407,5199,5143,0617,488
Upgrade
Net Cash Growth
32.20%-20.97%210.80%-59.12%-65.62%
Upgrade
Net Cash Per Share
1154.33873.871104.91355.50869.68
Upgrade
Filing Date Shares Outstanding
8.618.618.618.618.61
Upgrade
Total Common Shares Outstanding
8.618.618.618.618.61
Upgrade
Working Capital
38,99637,47234,76830,34928,037
Upgrade
Book Value Per Share
6385.985919.735609.935310.445103.62
Upgrade
Tangible Book Value
54,41350,32347,67344,73843,157
Upgrade
Tangible Book Value Per Share
6318.325844.375536.525195.725012.04
Upgrade
Land
7,0117,0117,0615,4645,464
Upgrade
Buildings
10,0846,4526,5336,4896,471
Upgrade
Machinery
10,0979,5479,3429,2559,222
Upgrade
Construction In Progress
540595.1341.651,6201,007
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.